Taiwan Speciality Chemicals Corporation

As of June 30, 2026, Taiwan Speciality Chemicals Corporation carries a market capitalization of 40.10B, placing it among publicly traded companies globally. Its enterprise value stands at 41.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Taiwan Speciality Chemicals Corporation's next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, Taiwan Speciality Chemicals Corporation has 147.68M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Taiwan Speciality Chemicals Corporation maintains a current ratio of 2.67, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Taiwan Speciality Chemicals Corporation recorded 203.78M in income tax expense.

As of the close on October 22, 2026, Taiwan Speciality Chemicals Corporation's stock has declined approximately 20.31% over the past 52 weeks. The 50-day moving average sits at 256.54, while the 200-day moving average is 288.83.

As of June 30, 2026, Taiwan Speciality Chemicals Corporation holds 2.48B in cash and equivalents against 2.63B in total debt, resulting in a net debt position of 150.87M. Total book value stands at 3.70B, with working capital of 2.05B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.